Return on Innovation: Why Global Health R&D is a Smart Investment for the United States
By Policy Cures Research (now Impact Global Health) 1 July 2017
A smart investment, delivering economic and security returns for Americans and catalysing the development of urgently-needed tools
The report explores the investments made and the role played by key US institutions such as the Agency for International Development, the National Institutes of Health, the Department of Defense and the Centers for Disease Control. It looks at the achievements delivered with the help of US investments, and how this investment has contributed to a pipeline of products to address global health needs.
US government investment of around $14 billion in R&D for global health has been a smart investment, delivering economic and security returns for Americans while playing an essential role as a catalyst for the development of new drugs, vaccines, diagnostics and other urgently-needed tools for fighting neglected disease.
PDF of the report